| Name | (1S,4aS,5S,7aS)-1-(β-D-Glucopyranosyloxy)-5-hydroxy-7-({[(methyls ulfanyl)carbonyl]oxy}methyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyr an-4-carboxylic acid |
|---|---|
| Synonyms |
paederosidic acid
(1S,4aS,5S,7aS)-1-(β-D-Glucopyranosyloxy)-5-hydroxy-7-({[(methylsulfanyl)carbonyl]oxy}methyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid Cyclopenta[c]pyran-4-carboxylic acid, 1-(β-D-glucopyranosyloxy)-1,4a,5,7a-tetrahydro-5-hydroxy-7-[[[(methylthio)carbonyl]oxy]methyl]-, (1S,4aS,5S,7aS)- |
| Description | Paederosidic acid is isolated from P. scandens with anticancer and anti‐inflammation activities. Paederosidic acid inhibits lung caner cells via inducing mitochondria-mediated apoptosis[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: apoptosis[1] |
| In Vitro | Paederosidic acid (40 μg/ml; 24 hours and 48 hours) has no significant effect on BSAS-2B cells, it exhibits obvious effects on NCI-H1650, HCC827, A549 cells with IC50 values of 40.68, 42.58, and 36.48 μg/ml, respectively[1]. Paederosidic acid induces mitochondria-mediated apoptosis via up-regulation of caspase-3, caspase-8, caspase-9, Bid, Bax, down-regulation of Bcl-2 and stimulating the release of Cyto-C from mitochondria in lung cancer cells[1]. . |
| References |
| Density | 1.7±0.1 g/cm3 |
|---|---|
| Boiling Point | 748.1±70.0 °C at 760 mmHg |
| Molecular Formula | C18H24O12S |
| Molecular Weight | 464.441 |
| Flash Point | 406.2±35.7 °C |
| Exact Mass | 464.098846 |
| PSA | 217.74000 |
| LogP | -1.48 |
| Vapour Pressure | 0.0±5.6 mmHg at 25°C |
| Index of Refraction | 1.666 |